ONCOGENIC TRANSFORMATION ALTERS CISPLATIN-INDUCED APOPTOSIS IN RAT EMBRYO FIBROBLASTS

被引：37

作者：

BASU, A

CLINE, JS

机构：

[1] Department of Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

来源：

INTERNATIONAL JOURNAL OF CANCER | 1995年 / 63卷 / 04期

关键词：

D O I：

10.1002/ijc.2910630422

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We have investigated whether cellular transformation by different oncogenes alters their responsiveness to the chemotherapeutic agent cis-diamminedichloroplatinum(II) (cDDP). Rat-6 (R6) embryo fibroblasts transformed by v-myc, rc-mos (rearranged mouse c-mos), v-src and activated c-H-ras oncogenes displayed differential sensitivities to cDDP, and the IC50 values of cDDP decreased by approximately 3.0-, 1.2-, 2.0- and 1.5-fold, respectively. Over-expression of myc, but not ras, src or mos, induced apoptosis in R6 cells. Nevertheless, all oncogenes influenced cellular susceptibility to apoptosis triggered by cDDP as judged by the appearance of condensed chromatin, formation of apoptotic bodies and internucleosomal cleavage of genomic DNA to 180 bp multimers, yielding a ''laddered'' electrophoretic profile on agarose gel. There was a correlation between the time- and concentration-dependent enhancement of cDDP-induced DNA fragmentation and potentiation of cDDP sensitivity by various oncogenes. Oncogenic transformation led to a decrease in expression of the PKC epsilon isoform, and stable transfection of PKC epsilon in R6 cells prevented cDDP-induced apoptosis and protected cells against cDDP cytotoxicity. Our results indicate that the differential sensitivity of oncogene-transformed cells to cDDP may be associated with the ability of various oncogenes to influence cDDP-induced apoptosis. (C) 1995 Wiley-Liss, Inc.

引用

页码：597 / 603

页数：7

共 25 条

[1] Basu A., The potential of protein kinase C as a target for anticancer treatment, Pharmacol. Ther., 59, pp. 257-280, (1993)
[2] Basu A., Lazo J.S., Sensitization of human cervical carcinoma cells to cis‐diamminedichloroplatinum (II) by bryostatin 1, Cancer Res., 52, pp. 3119-3124, (1992)
[3] Basu A., Teicher B.A., Lazo J.S., Involvement of protein kinase C in phorbol ester‐induced sensitization of HeLa cells to cis‐diamminedichloroplatinum(II), J. biol. Chem., 265, pp. 8451-8457, (1990)
[4] Basu A., Weixel K.M., Comparison of protein kinase activity and isoform expression in cisplatin‐sensitive and ‐resistant ovarian carcinoma cells, Int. J. Cancer, 62, pp. 457-460, (1995)
[5] Bissonnette R.P., Echeverri F., Mahboubi A., Green D.G., Apoptotic cell death induced by c‐myc is inhibited by bcl‐2., Nature (Lond.), 359, pp. 552-554, (1992)
[6] Borner C., Guadango S.N., Hsiao W.W.-L, Fabbro D., Barr M., Weinstein I.B., Expression of four protein kinase C isoforms in rat fibroblasts: differential alterations in ras‐, src‐ and fos‐transformed cells, J. biol. Chem., 267, pp. 12900-12910, (1992)
[7] Cacace A.M., Guadagno S.N., Krauss R.S., Fabbro D., Weinstein I.B., The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts, Oncogene, 8, pp. 2095-2104, (1993)
[8] Chen M.-J., Holskin B., Strickler J., Gorniak J., Clark M.A., Johnson P.J., Mitcho M., Shalloway D., Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF, Nature (Lond.), 330, pp. 581-583, (1987)
[9] Day M.L., Zhao X., Wu S., Swanson P.E., Humphrey P.A., Phorbol ester‐induced apoptosis is accompanied by NGFI‐A and c‐fos activation in androgen‐sensitive prostate cancer cells, Cell Growth Differentiation, 5, pp. 735-741, (1994)
[10] Eastman A., Activation of programmed cell death by anticancer agents: cisplatin as a model system, Cancer Cells, 2, pp. 275-279, (1990)

← 1 2 3 →